Company news
Egetis Therapeutics Ab (OMXSTO:EGTX) news
Every Egetis Therapeutics Ab press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Egetis Announces Grant of Patent for MCT8 Deficiency Composition in The U.S.
May 5, 2026
Egetis Appoints Tiago Nunes as Chief Medical Officer
April 9, 2026
Egetis Announces FDA Acceptance and Priority Review of NDA for Emcitate(R) (tiratricol) for MCT8 Deficiency
March 27, 2026
Egetis Receives Notice of Allowance for MCT8 Deficiency Composition Patent in the U.S.
March 9, 2026
Egetis Therapeutics Launches Educational Websites on MCT8 Deficiency for Physicians and Caregivers
March 2, 2026